- Home
- ELLO vs HRTX Comparison
ELLO vs HRTX Comparison
Compare ELLO & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELLO
- HRTX
- Stock Information
- Founded
- ELLO 1987
- HRTX 1983
- Country
- ELLO Israel
- HRTX United States
- Employees
- ELLO N/A
- HRTX N/A
- Industry
- ELLO Electric Utilities: Central
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- ELLO Utilities
- HRTX Health Care
- Exchange
- ELLO Nasdaq
- HRTX Nasdaq
- Market Cap
- ELLO 267.2M
- HRTX 242.0M
- IPO Year
- ELLO 1995
- HRTX 1987
- Fundamental
- Price
- ELLO $18.90
- HRTX $1.33
- Analyst Decision
- ELLO
- HRTX Strong Buy
- Analyst Count
- ELLO 0
- HRTX 2
- Target Price
- ELLO N/A
- HRTX $4.50
- AVG Volume (30 Days)
- ELLO 1.8K
- HRTX 1.6M
- Earning Date
- ELLO 09-30-2025
- HRTX 11-11-2025
- Dividend Yield
- ELLO N/A
- HRTX N/A
- EPS Growth
- ELLO N/A
- HRTX N/A
- EPS
- ELLO N/A
- HRTX N/A
- Revenue
- ELLO $48,322,959.00
- HRTX $149,694,000.00
- Revenue This Year
- ELLO N/A
- HRTX $10.62
- Revenue Next Year
- ELLO N/A
- HRTX $12.99
- P/E Ratio
- ELLO N/A
- HRTX N/A
- Revenue Growth
- ELLO N/A
- HRTX 9.78
- 52 Week Low
- ELLO $11.84
- HRTX $1.04
- 52 Week High
- ELLO $23.69
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- ELLO 54.99
- HRTX 49.45
- Support Level
- ELLO $17.73
- HRTX $1.29
- Resistance Level
- ELLO $23.69
- HRTX $1.37
- Average True Range (ATR)
- ELLO 0.93
- HRTX 0.06
- MACD
- ELLO 0.12
- HRTX 0.02
- Stochastic Oscillator
- ELLO 27.97
- HRTX 73.68
About ELLO Ellomay Capital Ltd (Israel)
Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.